SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ZILA--test for oral cancer?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ivan Andrew who wrote (11)6/5/1996 1:50:00 AM
From: Mark Fleming   of 61
 
Ivan: ZILA's web site has a new press release that answers your questions:

1) I believe OraTest will be the U.S. name for the product known as OraScan in another country. 2) My understanding is that, yes, ZILA appears to have given up on licensing a big distributor like J&J. ZILA explains their rationale for the selection in the press release; they claim the merger with BDTC should benefit shareholders more in the long run than the alternatives because of synergies from the merger, greater control over marketing and distribution, and less sacrifice of profits to a larger distributor. The union seems to me to add confidence to the chances of regulatory approval. I wonder if the merger is conditional on regulatory approval or if they will merge regardless.

Mark
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News